SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 10th, 2017 • Lixte Biotechnology Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 10th, 2017 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT this (“Agreement”), dated as of April 3, 2017, by and among Lixte Biotechnology Holdings, Inc., a Delaware corporation (the “Company”), and Hung Tak Ho (“Purchaser”).